These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29861018)

  • 21. The use of Apligraf in acute wounds.
    Kirsner RS
    J Dermatol; 1998 Dec; 25(12):805-11. PubMed ID: 9990773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-stage application of a novel decellularized dermis for treatment-resistant lower limb ulcers: positive outcomes assessed by SIAscopy, laser perfusion, and 3D imaging, with sequential timed histological analysis.
    Greaves NS; Benatar B; Baguneid M; Bayat A
    Wound Repair Regen; 2013; 21(6):813-22. PubMed ID: 24134424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hair follicle-containing punch grafts accelerate chronic ulcer healing: A randomized controlled trial.
    Martínez ML; Escario E; Poblet E; Sánchez D; Buchón FF; Izeta A; Jimenez F
    J Am Acad Dermatol; 2016 Nov; 75(5):1007-1014. PubMed ID: 27745629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf).
    Karr JC
    Adv Skin Wound Care; 2011 Mar; 24(3):119-25. PubMed ID: 21326023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost effectiveness of Apligraf treatment of diabetic foot ulcers.
    Redekop WK; McDonnell J; Verboom P; Lovas K; Kalo Z
    Pharmacoeconomics; 2003; 21(16):1171-83. PubMed ID: 14594438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ulcers associated with polyarteritis nodosa treated with bioengineered human skin equivalent (Apligraf).
    Pennoyer JW; Susser WS; Chapman MS
    J Am Acad Dermatol; 2002 Jan; 46(1):145. PubMed ID: 11756967
    [No Abstract]   [Full Text] [Related]  

  • 27. A bioengineered living cell construct activates metallothionein/zinc/MMP8 and inhibits TGFβ to stimulate remodeling of fibrotic venous leg ulcers.
    Stone RC; Stojadinovic O; Sawaya AP; Glinos GD; Lindley LE; Pastar I; Badiavas E; Tomic-Canic M
    Wound Repair Regen; 2020 Mar; 28(2):164-176. PubMed ID: 31674093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health-related quality of life in venous leg ulcer patients successfully treated with Apligraf: a pilot study.
    Mathias SD; Prebil LA; Boyko WL; Fastenau J
    Adv Skin Wound Care; 2000; 13(2):76-8. PubMed ID: 11074990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of pinch grafting in leg ulcers of different aetiologies.
    Ahnlide I; Bjellerup M
    Acta Derm Venereol; 1997 Mar; 77(2):144-5. PubMed ID: 9111828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of living bilayered cell therapy (Apligraf) for heel ulcers.
    Karr J
    Adv Skin Wound Care; 2008 Jun; 21(6):270-4. PubMed ID: 18525250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of Apligraf in the treatment of venous leg ulcers.
    Sibbald RG; Torrance GW; Walker V; Attard C; MacNeil P
    Ostomy Wound Manage; 2001 Aug; 47(8):36-46. PubMed ID: 11890002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers.
    Falanga V; Sabolinski M
    Wound Repair Regen; 1999; 7(4):201-7. PubMed ID: 10781211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of Apligraf in the treatment of venous leg ulcers.
    Dolynchuk K; Hull P; Guenther L; Sibbald RG; Brassard A; Cooling M; Delorme L; Gulliver W; Bourassa DH; Ho V; Kunimoto B; Overholt T; Papp K; Tousignant J
    Ostomy Wound Manage; 1999 Jan; 45(1):34-43. PubMed ID: 10085970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Confirmatory data from EU study supports Apligraf for the treatment of neuropathic diabetic foot ulcers.
    Steinberg JS; Edmonds M; Hurley DP; King WN
    J Am Podiatr Med Assoc; 2010; 100(1):73-7. PubMed ID: 20093548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers.
    Saap LJ; Donohue K; Falanga V
    Dermatol Surg; 2004 Aug; 30(8):1095-100. PubMed ID: 15274699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apligraf treatment of venous ulcers and other chronic wounds.
    Falanga V
    J Dermatol; 1998 Dec; 25(12):812-7. PubMed ID: 9990774
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel treatment strategy for leg and sternal wound complications after coronary artery bypass graft surgery: bioengineered Apligraf.
    Allie DE; Hebert CJ; Lirtzman MD; Wyatt CH; Keller VA; Souther SM; Allie AA; Mitran EV; Walker CM
    Ann Thorac Surg; 2004 Aug; 78(2):673-8; discussion 678. PubMed ID: 15276544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healing of Recalcitrant Chronic Venous Leg Ulcers by Punch Grafts Harvested From the Scalp.
    Martínez Martínez ML; Escario Travesedo E; Jiménez Acosta F
    Dermatol Surg; 2015 Sep; 41(9):1085-7. PubMed ID: 26262948
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes.
    Barber C; Watt A; Pham C; Humphreys K; Penington A; Mutimer K; Edwards M; Maddern G
    J Wound Care; 2008 Dec; 17(12):517-27. PubMed ID: 19052516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous full-thickness skin substitute for healing chronic wounds.
    Gibbs S; van den Hoogenband HM; Kirtschig G; Richters CD; Spiekstra SW; Breetveld M; Scheper RJ; de Boer EM
    Br J Dermatol; 2006 Aug; 155(2):267-74. PubMed ID: 16882162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.